Speakers at ESCAIDE 2019
Plenary session B: “Vaccine confidence in a post-factual world”
Dr. Wolfgang Gaissmaier
Wolfgang Gaissmaier (*1977), PhD, has been a Full Professor of Social Psychology and Decision Sciences at the University of Konstanz, Germany, since 2014. His research investigates how people make decisions under uncertainty and how risks can be communicated more successfully to help people make better decisions, particularly in medicine. He received his PhD in 2007 (Free University Berlin) and his habilitation (venia legendi) in 2013 (University of Heidelberg). For many years, he worked as Chief Research Scientist at the Harding Center for Risk Literacy at the Max Planck Institute for Human Development, Berlin. Wolfgang Gaissmaier’s work has been published in leading psychological and medical journals, including Annals of Internal Medicine, Annual Review of Psychology, Cognition, Health Psychology, JAMA, PNAS, and Psychological Science. He received numerous awards, including the Otto Hahn Medal for outstanding scientific achievements by the Max Planck Society (2008), a fellowship at the Young Academy of the Berlin-Brandenburg Academy of Sciences and Humanities and the German Academy of Sciences Leopoldina (2012-2017), a rising star nomination by the Association for Psychological Science (2013), and an award for excellent teaching and being a positive role model by the students of the University of Konstanz (2016 and 2019).
Plenary session C: “The microbiome: what you need to know”
Invited speaker: Dr. Sean Gibbons
Sean Gibbons earned his PhD in biophysics from the University of Chicago in 2015. He completed his postdoctoral work at MIT in 2018. Sean is now an assistant professor at the Institute for Systems Biology, in Seattle. His lab studies the ecology and evolution of microbial communities. In particular, Sean is interested in how host-associated bacterial communities influence the health and wellness of the host organism. His group designs computational and wet-lab tools for studying these complex systems. Ultimately, the Gibbons Lab aims to develop strategies for engineering the ecology of the gut microbiome to improve human health.